comparemela.com

Page 29 - Cdsco News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Shot in the Back: PM CARES Hasn t Given Rs 100 Crore to Develop COVID Vaccines

None of the departments associated with India's COVID-19 vaccine development efforts received any money from the fund.

New delhiNarendra modiCommodore lokesh batraK vijayraghavanPm care fundVaccine administration cellCentral drug standards control organisationIndian council of medical researchDepartment of biotechnologyPrime minister narendra modiPrime ministerPrincipal scientific advisorCentral public information officerAdministration cellIndian councilMedical research

CoSara Diagnostics bags CDSCO clearance for high-risk HPV multiplex test

The multiplex test is built on the company's patented CoPrimer technology

Central drugs standard control organizationCosara diagnosticsPapillomavirus high riskCo diagnosticsCosara diagnostics

Guidelines On Covaxin For 15-18 Age Group Do Not Mention EUL By WHO: Govt Slams Ill-Informed, Misleading Media Reports

Guidelines On Covaxin For 15-18 Age Group Do Not Mention EUL By WHO: Govt Slams Ill-Informed, Misleading Media Reports
swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.

Union health ministry onUnion health ministryCentral drugs standard control organisationWorld health organisationEmergency use listingHealth ministry

Molnupiravir, COVID-19 Antiviral Drug, Launched in India at Rs 1,399 For Mild to Moderate Infection

Covid antiviral drug Molnupiravir was on Monday launched in India at Rs 1,399 for a five-day course for mild to moderate infection. Molnupiravir, COVID-19 Antiviral Drug, Launched in India at Rs 1,399 For Mild to Moderate Infection.

Andhra pradeshUnited kingdomNew delhiSun pharmaRidgeback biotherapeuticsHealth expert dr krishna reddy nallamallaSerum institute of india covidDrug administrationCentral drugs standard control organisationSerum instituteMolnupiravir may reduce riskNewly diagnosed patientsSays health expert dr krishna reddyCoronavirus antiviral drugCovid 19 antiviral drugCovid 19 drug

Molnupiravir, Covid-19 pill for India, launched by Hyderabad s Optimus Pharma

Hyderabad-based Optimus Pharma has launched its Covid-19 pill molnupiravir after receiving approval for emergency use in the treatment of Covid-19 high-risk patients.

D srinivasa reddyOptimus pharmaCentral drugs standard control organisationHyderabad based optimus pharmaDrugs controller generalOptimus pharmaCovid 19 pillCovid medicineOvid oral pill

vimarsana © 2020. All Rights Reserved.